Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate

Senti Biosciences (NASDAQ: SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share from the same period last year.